Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nevada
Clinical trial register · United States · industry-sponsored

Clinical Trials in Nevada, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9148 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 21 Nov 2026, 03:16 UTC
9148
Studies in scope
industry-sponsored, all four open statuses
4975
Recruiting now
open to new participants
2181
Lead sponsors
across recruiting studies
Top states
California 5328 Florida 4488 Illinois 2493 Georgia 2364 Arizona 2269

Trials with a site in Nevada

312 of 9148 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
Gedeon Richter Plc.
Phase 2
156
California, Florida, Nevada, New York, North Carolina, Tennessee
2026-11-12
Recruiting
Novartis Pharmaceuticals
Phase 3
340
Alabama, California, Delaware, Florida, Georgia, Nevada, Virginia
2026-11-11
Recruiting
Eli Lilly and Company
Phase 2
330
California, Florida, Georgia, Massachusetts, Nevada, New Jersey, New York, Pennsylvania
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
450
California, Florida, Nevada, New York, North Carolina, South Carolina, Tennessee, Texas
2026-11-10
Recruiting
Pfizer
Phase 3
600
Florida, Minnesota, Nevada, New York, Ohio, Oregon, Tennessee, Texas
2026-11-05
Recruiting
Daiichi Sankyo
Phase 3
200
Maryland, Nevada, Tennessee, Texas, Virginia
2026-11-04
Not yet open
BrocShot Inc
Not applicable
50
Nevada
2026-11
Not yet open
The Collagen Co. - GLP-1 Users
Not applicable
40
Nevada
2026-11
Not yet open
Driscoll's
Not applicable
40
Nevada
2026-11
Not yet open
Epetome
Not applicable
40
Nevada
2026-11
Recruiting
Hoffmann-La Roche
Phase 3
400
California, Florida, Georgia, Massachusetts, Michigan, Nevada, New Mexico, Ohio
2026-10-06
Not yet open
A Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-being
NCT07903480Menopause, Menopausal Symptoms, Hot Flashes, Night Sweats
Primal Harvest, LLC
Not applicable
40
Nevada
2026-10
Recruiting
Vivance Group
Not applicable
45
Nevada
2026-10
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
NCT07520006B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Nurix Therapeutics, Inc.
Phase 1/2
150
California, Colorado, Florida, Kansas, Nevada, New Jersey, Oregon, Pennsylvania
2026-09-30
Recruiting
Biojiva LLC
Phase 1/2
152
Arizona, Mississippi, Nevada, Ohio, Texas, Utah, Washington
2026-09-29
Recruiting
Phathom Pharmaceuticals, Inc.
Phase 3
500
Arizona, California, Colorado, Florida, Georgia, Idaho, Nevada, New York
2026-09-25
Recruiting
Puma Biotechnology, Inc.
Phase 2
50
Nevada
2026-09-17
Recruiting
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
NCT07570654PTSD - Post Traumatic Stress Disorder, PTSD, PTSD Symptoms, PTSD, Post Traumatic Stress Disorder
COMPASS Pathways
Phase 2/3
300
Arizona, California, Florida, Illinois, Massachusetts, Minnesota, Nebraska, Nevada
2026-09-14
Recruiting
A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.
NCT07893561Improves Daytime Energy Levels, Reduces Afternoon Energy Crashes and Midday Fatigue, Improves Overall Sleep Quality and Restorative Sleep, Helps People Fall Asleep Faster and Wake Less During the Night
Bioligent
Not applicable
40
Nevada
2026-09-09
Active, closed
A Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental Clarity
NCT07892911Fatigue, Low Mood, Mental Clarity, Iron Deficiency
Ancestral Supplements, LLC
Not applicable
100
Nevada
2026-09-01
Recruiting
GlaxoSmithKline
Phase 3
110
Florida, Kentucky, Missouri, Nevada, Oregon, South Carolina, Texas
2026-09-01
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
80
Florida, Louisiana, Massachusetts, Missouri, Nevada, New Jersey, New York, Ohio
2026-09-01
Recruiting
A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood
NCT07753174Omega-3 Deficiency, DHA and EPA Blood Levels, Cardiovascular Health, Cognitive Health
Revive Active
Not applicable
49
Nevada
2026-09
Recruiting
Clean Nutraceuticals
Not applicable
35
Nevada
2026-09
Not yet open
A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal Women
NCT07893795Relieves Vaginal Dryness / Improves Self-Lubrication, Improves Strength & Elasticity of Vagina (Aka Collagen and Elastin), Improves Vaginal Wall Thickness, Reduces Pain During Sex
NeuEve
Not applicable
40
Nevada
2026-09
Recruiting
Brexanolone Lifting Outcomes Of Moms
NCT07822321Depression, Postpartum, Postpartum Depression (PPD), Post-partum Depression, Postnatal Depression
Lipocine Inc.
Phase 3
120
Arizona, California, Colorado, Georgia, Idaho, Illinois, Louisiana, Nevada
2026-09
Recruiting
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 3
160
Indiana, Massachusetts, Nevada, North Carolina, Ohio, Pennsylvania, Texas
2026-08-31
Recruiting
A Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in Children
NCT07893626Nutrient Gap in Children, Pediatric Health and Well-Being, Immune Health, Growth and Development
Hiya Health
Not applicable
40
Nevada
2026-08-31
Active, closed
A Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite Control
NCT07895563Overweight, Obesity, Weight Management, Appetite Control
MNnutra
Not applicable
170
Nevada
2026-08-27
Recruiting
MBX Biosciences
Phase 3
160
California, Colorado, Florida, Georgia, Louisiana, Mississippi, Nebraska, Nevada
2026-08-26
Recruiting
Genentech, Inc.
Phase 3
300
Alabama, California, Connecticut, District of Columbia, Michigan, Nevada, New Jersey, New Mexico
2026-08-25
Recruiting
AstraZeneca
Phase 3
500
California, Florida, Georgia, Illinois, Maryland, Missouri, Nevada, New Jersey
2026-08-24
Recruiting
Vensica Therapeutics Ltd.
Phase 2
210
Florida, Nevada
2026-08-14
Recruiting
Novo Nordisk A/S
Phase 3
450
Alabama, California, Florida, Hawaii, Kentucky, Missouri, Nevada, Oregon
2026-08-12
Recruiting
Alkermes, Inc.
Phase 2
312
Arkansas, California, Florida, Georgia, Massachusetts, Michigan, Nebraska, Nevada
2026-08-10
Recruiting
Corium Innovations, Inc.
Phase 1
250
Nevada
2026-08-10
Active, closed
Amgen
Phase 1
28
Nevada
2026-08-07
Recruiting
Nektar Therapeutics
Phase 3
510
Alabama, California, Florida, Georgia, Louisiana, Missouri, Nevada, New Jersey
2026-08-07
Recruiting
Sling Therapeutics, Inc.
Phase 3
130
Arizona, California, Florida, Massachusetts, Michigan, Nevada, New Jersey, New York
2026-08-04
Active, closed
A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function
NCT07883525Cognition Improvement, Cognition Function
Necternal LLC
Not applicable
128
Nevada
2026-08-01
Recruiting
GlaxoSmithKline
Phase 1
8
Nevada
2026-07-23
Recruiting
Gilead Sciences
Phase 1
112
California, District of Columbia, Florida, Georgia, Indiana, Massachusetts, Nevada, New Jersey
2026-07-22
Recruiting
Regeneron Pharmaceuticals
Phase 4
30
California, Florida, Louisiana, Maryland, Nevada, Texas, Washington
2026-07-15
Recruiting
argenx
Phase 2
40
California, Florida, Nevada, New York, Tennessee, Texas
2026-07-10
Active, closed
Rejuvaskin
Not applicable
35
Nevada
2026-07-06
Recruiting
Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
NCT07885605Thyroid Eye Disease (TED), Graves' Disease, Eye Diseases, Hereditary, Eye Diseases
Ethyreal Bio, Inc.
Phase 1
72
Illinois, Nevada, North Carolina
2026-07-06
Active, closed
SuperBonsai Inc.
Not applicable
35
Nevada
2026-07-02
Active, closed
Larine C Corporation
Not applicable
40
Nevada
2026-07-02
Recruiting
RAI Services Company
Not applicable
1,060
Florida, Illinois, Nevada, Texas
2026-07
Recruiting
Neuvosyn Laboratories, LLC
Phase 3
466
California, Colorado, Florida, Idaho, Massachusetts, Nevada, North Carolina, South Carolina
2026-06-30
Recruiting
PureTech
Phase 3
1,100
California, Florida, Massachusetts, Nevada, North Carolina, Pennsylvania, South Carolina, Tennessee
2026-06-26
Active, closed
A Clinical Trial to Evaluate the Effects of Super Liver Liquid Drops on Gut Health, Digestive Comfort, and Daily Energy Levels
NCT07742657Gastrointestinal Symptoms, Bloating, Digestive Discomfort, Low Energy Levels
SuperBonsai Inc.
Not applicable
35
Nevada
2026-06-24
Recruiting
Just-Evotec Biologics
Phase 1
48
Nevada
2026-06-23
Recruiting
PleoPharma, Inc.
Phase 3
420
Arkansas, Connecticut, Florida, Georgia, Kentucky, Maryland, Nevada, New Jersey
2026-06-17
Recruiting
AstraZeneca
Phase 3
150
California, Georgia, Illinois, Kentucky, Nevada, South Dakota, Tennessee, Texas
2026-06-15
Active, closed
BioAge Labs, Inc.
Phase 2
160
Arizona, Arkansas, Florida, Kentucky, Maryland, Missouri, Nevada, New York
2026-06-11
Recruiting
Castle Biosciences Incorporated
Observational
450
Arizona, California, Florida, Maryland, Michigan, Missouri, Nevada, New Hampshire
2026-06-04
Not yet open
Evaluation of the Efficacy, Safety, and Tolerability of LevoCept
NCT04457076Contraception, Women at Risk for Pregnancy
Sebela Women's Health Inc.
Phase 3
1,525
California, Colorado, Georgia, Hawaii, Indiana, Minnesota, Missouri, Nevada
2026-06-01
Active, closed
Artah Nutrition Limited
Not applicable
50
Nevada
2026-06-01
Recruiting
Eli Lilly and Company
Phase 3
252
California, Florida, Idaho, Massachusetts, Michigan, Nevada, Pennsylvania, Utah
2026-06-01
Recruiting
The Impact of Enhanced Music & Natural Visuals on Emotional Health
NCT07676110Emotion Management Skills, Lifestyle, Healthy, Lifestyle Intervention, Recovery
soundBrilliance LLC
Not applicable
200
Colorado, Nebraska, Nevada
2026-05-25
Recruiting
Aspeya, Inc.
Phase 2
108
Arizona, California, Connecticut, Florida, Georgia, Massachusetts, Missouri, Nevada
2026-05-19
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
Pfizer
Phase 2/3
840
California, Colorado, Florida, Illinois, Kansas, Maryland, Missouri, Nevada
2026-05-14
Recruiting
Intuitive Surgical
Phase 3
146
California, Connecticut, Florida, Nevada, Ohio, Texas, Washington
2026-05-14
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 2
34
California, Florida, Georgia, Hawaii, Illinois, Nevada, North Carolina, South Carolina
2026-05-13
Recruiting
J-Pharma Co., Ltd.
Phase 3
480
California, Florida, Illinois, Kentucky, Louisiana, Michigan, Minnesota, Nevada
2026-05-11
Recruiting
Corxel Pharmaceuticals
Phase 1
90
Nevada, Texas
2026-05-11
Recruiting
AstraZeneca
Phase 2
104
Arizona, California, Florida, Missouri, Nevada, North Carolina, Ohio, Oklahoma
2026-05-07
Recruiting
Ascendis Pharma Bone Diseases A/S
Phase 3
36
Colorado, Illinois, Minnesota, Nevada, New Jersey, New York, North Carolina, Texas
2026-05-07
Recruiting
Kriya Therapeutics, Inc.
Phase 1/2
135
Michigan, Nevada, Pennsylvania
2026-05-01
Recruiting
Biomea Fusion Inc.
Phase 2
60
Alabama, California, Florida, Georgia, Nevada, North Carolina, Ohio, Texas
2026-04-30
Recruiting
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
NCT07342478CLL / SLL, CLL (Chronic Lymphocytic Leukemia), CLL, Refractory, CLL, Relapsed
Newave Pharmaceutical Inc
Phase 3
306
Illinois, Maryland, Nevada, North Carolina, Ohio, Pennsylvania, Washington
2026-04-23
Recruiting
Aurinia Pharmaceuticals Inc.
Phase 4
150
California, Colorado, Florida, Georgia, Louisiana, Maryland, Missouri, Nevada
2026-04-22
Recruiting
Medtronic
Observational
970
Arizona, California, Missouri, Nebraska, Nevada, Pennsylvania, Texas
2026-04-17
Active, closed
A Clinical Trial to Evaluate the Effects of a Supplement on Urinary Symptoms
NCT07947108Urinary Tract Infection, Recurrent Urinary Tract Infection, Urinary Symptoms
Good Kitty Co
Not applicable
44
Nevada
2026-04-17
Recruiting
Novo Nordisk A/S
Phase 3
400
Arizona, California, Connecticut, Florida, Georgia, Idaho, Massachusetts, Nevada
2026-04-13
Active, closed
A Study to Evaluate the Effects of the EMF Harmony Products on Health Parameters Associated With EMF Radiation Exposure
NCT07950033Electromagnetic Hypersensitivity, Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields, Sleep Disturbance, Brain Fog
Life Harmony Energies, Inc.
Not applicable
60
Nevada
2026-04-07
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Arizona, Arkansas, California, Florida, Maryland, Michigan, Missouri, Nevada
2026-04-02
Recruiting
Bausch Health Americas, Inc.
Phase 4
100
Arkansas, California, Florida, Kentucky, Michigan, Nevada, New York, North Carolina
2026-04-01
Recruiting
Palvella Therapeutics, Inc.
Phase 2
15
California, Georgia, Nevada, Texas
2026-04
Active, closed
Biomea Fusion Inc.
Phase 2
64
Alabama, California, Florida, Georgia, Nevada, Ohio, Texas, Virginia
2026-03-27
Recruiting
ModeX Therapeutics, An OPKO Health Company
Phase 1
80
Nevada, Texas
2026-03-24
Active, closed
A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy
NCT07766642Difficulty Focusing, Poor Concentration, Poor Memory, Low Energy
Auri Nutrition
Not applicable
35
Nevada
2026-03-13
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 3
900
Arizona, California, Florida, Maryland, Massachusetts, Michigan, Minnesota, Nevada
2026-03-09
Active, closed
Amgen
Phase 2
180
Arizona, California, Florida, Louisiana, Maryland, Missouri, Nevada, Texas
2026-03-05
Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
NCT07484217Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc.
Phase 3
508
Arizona, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Nevada
2026-02-23
Recruiting
A Clinical Trial to Evaluate the Effects of a Supplement on Gut Health
NCT07927907Gut Health, Bloating, Digestive Discomfort, Constipation
Peach Perfect
Not applicable
40
Nevada
2026-02-01
Recruiting
Renal Pelvic Denervation Pilot Trial
NCT07005050Uncontrolled Hypertension
Verve Medical, Inc
Not applicable
60
Alabama, Arizona, California, Illinois, Iowa, Minnesota, Nevada, Texas
2026-01-30
Recruiting
Tempus AI
Observational
550
Iowa, Maryland, Missouri, Nevada, New York, North Carolina, North Dakota, Ohio
2026-01-27
Recruiting
LB Pharmaceuticals Inc.
Phase 2
320
Arkansas, California, Florida, Georgia, Illinois, Michigan, Missouri, Nevada
2026-01-23
Recruiting
Bristol-Myers Squibb
Phase 4
60
Arkansas, California, Florida, Illinois, Nevada, New Jersey, Pennsylvania, Texas
2026-01-20
Recruiting
AstraZeneca
Phase 4
16
Nevada
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
400
California, District of Columbia, Florida, Georgia, Idaho, Illinois, Massachusetts, Nevada
2026-01-16
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 3
80
California, Colorado, Nevada, Ohio, Texas, Utah
2026-01-14
Recruiting
Complement Therapeutics
Phase 1/2
75
Indiana, Nevada, Texas, Wisconsin
2025-12-30
Recruiting
argenx
Observational
70
California, Florida, Massachusetts, Michigan, Nevada, New York, North Carolina, Ohio
2025-12-19
Recruiting
argenx
Phase 2
70
California, Florida, Massachusetts, Michigan, Nevada, New York, North Carolina, Ohio
2025-12-19
Recruiting
AbbVie
Phase 2
195
Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Nevada
2025-12-18
Active, closed
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
NCT07246590Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts
Verrica Pharmaceuticals Inc.
Phase 3
302
Florida, Idaho, Indiana, Louisiana, Maryland, Michigan, Nebraska, Nevada
2025-12-17
Active, closed
TaiMed Biologics Inc.
Phase 2
88
California, Florida, Nevada, New York, Texas
2025-12-16
Recruiting
Draig Therapeutics Ltd
Phase 2
300
Arkansas, California, Florida, Georgia, Maryland, Massachusetts, Mississippi, Nevada
2025-12-16
Recruiting
HALEON
Observational
375
Nevada
2025-12-16
Recruiting
A Study of NTX-1472 in Social Anxiety Disorder
NCT07323784Social Anxiety Disorder (SAD)
Newleos Therapeutics, Inc.
Phase 2
100
California, Florida, Massachusetts, Nevada, New York, Tennessee, Texas
2025-12-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Maryland, Michigan, Nevada, New Jersey, Utah, Virginia
2025-12-04
Recruiting
Eli Lilly and Company
Phase 1
141
Alabama, Arizona, Florida, Nevada
2025-12-02
Recruiting
Pfizer
Phase 1/2
138
Arizona, California, Florida, Illinois, Massachusetts, Minnesota, Missouri, Nevada
2025-12-01
Recruiting
Debiopharm International SA
Phase 3
119
California, Illinois, Massachusetts, Missouri, Nevada, New York, Ohio, Oregon
2025-11-26
Recruiting
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
NCT07209397Overactive Bladder, Overactive Bladder (OAB), Urge Urinary Incontinence, Mixed Urinary Incontinence (Urge-Predominant)
InMode MD Ltd.
Not applicable
202
California, District of Columbia, Idaho, Illinois, Kansas, Massachusetts, Nebraska, Nevada
2025-11-25
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Arizona, California, Florida, Maryland, Nevada, Pennsylvania, Texas, Utah
2025-11-10
Recruiting
Sanofi
Phase 2
208
Arizona, California, Florida, Georgia, Iowa, Louisiana, Missouri, Nevada
2025-11-06
Recruiting
Bristol-Myers Squibb
Phase 2/3
661
California, Colorado, Florida, Georgia, Illinois, Massachusetts, Missouri, Nevada
2025-11-05
Active, closed
Novo Nordisk A/S
Phase 3
330
Alabama, Arizona, California, Florida, Hawaii, Indiana, Nevada, New York
2025-11-05
Recruiting
Eli Lilly and Company
Phase 2
222
Arkansas, Florida, Georgia, Michigan, Missouri, Nevada, New York, South Carolina
2025-11-03
Recruiting
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
NCT07332000Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Candel Therapeutics, Inc.
Phase 2
45
Arizona, Colorado, Maryland, Nevada, New Jersey, South Carolina
2025-10-30
Active, closed
Kylonova (Xiamen) Biopharma co., LTD.
Phase 2
204
California, Florida, Georgia, Louisiana, Nevada, North Carolina
2025-10-29
Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
NCT07211178Breast Cancer, TNBC - Triple-Negative Breast Cancer, HR Positive/HER-2 Negative Breast Cancer, HER2 + Breast Cancer
Tempus AI
Observational
900
Alabama, California, Florida, Illinois, Indiana, Michigan, Missouri, Nevada
2025-10-27
Recruiting
Eli Lilly and Company
Phase 2
531
Arizona, California, Colorado, Florida, Illinois, Kentucky, Massachusetts, Nevada
2025-10-22
By invitation
Vivio At-Home Study
NCT07730268Heart Failure
Ventric Health, LLC
Not applicable
500
California, Nevada
2025-10-20
Active, closed
Eli Lilly and Company
Phase 2
200
Arizona, Florida, Georgia, Nevada, New Jersey, Ohio, Texas, Utah
2025-10-16
Recruiting
Sanofi
Phase 1/2
104
Arizona, California, Florida, Georgia, Illinois, Maryland, Nevada, North Carolina
2025-10-09
By invitation
Iantrek, Inc.
Observational
250
California, Florida, Georgia, Maryland, Nevada, Pennsylvania, Tennessee, Utah
2025-09-15
Active, closed
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
NCT07207408Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis
Dynavax Technologies Corporation
Phase 2
148
Florida, Kansas, Nevada, Ohio
2025-09-11
Active, closed
AstraZeneca
Phase 1/2
405
California, Florida, Georgia, Illinois, Kansas, Missouri, Nebraska, Nevada
2025-09-04
Recruiting
MapLight Therapeutics
Phase 2
300
Arizona, California, Colorado, Florida, Georgia, Louisiana, Nevada, New Jersey
2025-08-15
Recruiting
AbbVie
Phase 1/2
66
Indiana, Nevada, Texas
2025-08-13
Recruiting
Outliers, Inc.
Not applicable
90
Nevada
2025-08-12
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT07096674Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugORX750
Centessa Pharmaceuticals (UK) Limited
Phase 2
90
Alabama, California, Florida, Georgia, Michigan, Nevada, North Carolina, Ohio
2025-08-12
Active, closed
Xenon Pharmaceuticals Inc.
Phase 3
400
Arizona, Arkansas, California, Florida, Georgia, Illinois, Missouri, Nevada
2025-08-08
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Arizona, California, Florida, Hawaii, Kansas, Massachusetts, Missouri, Nevada
2025-08-07
Recruiting
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
NCT07144137Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics
Observational
75
California, Illinois, Indiana, Nevada, North Carolina, Pennsylvania, Texas, Wisconsin
2025-07-30
Active, closed
Zenchi, Inc.
Not applicable
42
Nevada
2025-07-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Alabama, Arizona, California, Colorado, Delaware, Florida, Kentucky, Nevada
2025-07-21
Active, closed
Daiichi Sankyo
Phase 1
17
California, Georgia, Nevada, North Carolina, Ohio, Tennessee
2025-07-17
Recruiting
Biostar Pharma, Inc.
Phase 2
120
California, Colorado, Georgia, Illinois, Maryland, Nevada, New York, Texas
2025-07-14
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
AstraZeneca
Phase 3
473
California, Florida, Georgia, Illinois, Louisiana, Nevada, New York, North Carolina
2025-06-10
Recruiting
The Role of hCG in Thawed Embryo Transfer
NCT07004192Infertility (IVF Patients)
Fertility Center of Las Vegas
Phase 4
220
Nevada
2025-06-02
Recruiting
Neurocrine Biosciences
Phase 3
200
California, Colorado, Connecticut, Florida, Illinois, Maryland, Nevada, New Jersey
2025-05-30
Active, closed
Paradigm Biopharmaceuticals Ltd.
Phase 3
466
Arizona, California, Florida, Illinois, Maryland, Michigan, Nebraska, Nevada
2025-05-29
Active, closed
Upstream Bio Inc.
Phase 2
396
California, Florida, Idaho, Maryland, Michigan, Nevada, New York, Ohio
2025-05-21
Recruiting
Ageless Biotech, Inc.
Phase 2
400
Nevada
2025-05-21
Active, closed
Just-Evotec Biologics
Phase 1
104
Nevada
2025-05-16
Recruiting
Vanda Pharmaceuticals
Phase 3
400
Arkansas, California, Florida, Georgia, Illinois, Mississippi, Missouri, Nevada
2025-05-14
Active, closed
Eli Lilly and Company
Phase 3
465
California, Colorado, Florida, Iowa, Minnesota, Missouri, Nevada, North Carolina
2025-05-12
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
i-Lumen Scientific AUS PTY LTD
Not applicable
100
California, Connecticut, Illinois, Nevada, Ohio, Texas
2025-05-07
Active, closed
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
NCT07354308Overweight, Metabolic Health, Insulin Resistance
SP Nutraceuticals Inc.
Not applicable
60
Nevada
2025-05-01
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
California, Florida, Georgia, Massachusetts, Michigan, Mississippi, Nevada, New Jersey
2025-05-01
Active, closed
Hoffmann-La Roche
Phase 1
56
Arizona, Georgia, Louisiana, Nevada, Tennessee, Texas
2025-04-14
Recruiting
Coherus Oncology, Inc.
Phase 1
154
Arizona, California, Colorado, Georgia, Louisiana, Michigan, Nevada, New Mexico
2025-04-01
Active, closed
Acoustic Wave Cell Therapy, Inc.
Not applicable
130
Arizona, Florida, Idaho, Kansas, Montana, Nevada, Ohio, Texas
2025-03-25
Recruiting
Baxis Pharmaceuticals, Inc.
Phase 3
400
Arkansas, California, Florida, Georgia, Idaho, Illinois, Maryland, Nevada
2025-03-21
Active, closed
Hoffmann-La Roche
Phase 4
274
California, Florida, Illinois, Massachusetts, Nevada, New Jersey, New Mexico, Tennessee
2025-03-14
Recruiting
Halozyme Therapeutics
Phase 3
100
California, Colorado, Florida, Illinois, Massachusetts, Minnesota, Missouri, Nevada
2025-03-07
Recruiting
Novartis Pharmaceuticals
Phase 2
20
Alabama, California, Florida, Georgia, Idaho, Nevada, Ohio, Texas
2025-02-21
Recruiting
Impax Laboratories, LLC
Phase 4
220
Arizona, Arkansas, California, Florida, Illinois, Kansas, Michigan, Nevada
2025-02-12
Active, closed
Rivermark Medical
Not applicable
215
California, Colorado, Florida, Illinois, Louisiana, Michigan, Nevada, New York
2025-02-10
Active, closed
Apothekary
Not applicable
40
Nevada
2025-02-07
By invitation
Pharvaris Netherlands B.V.
Phase 3
170
Alabama, Arizona, Arkansas, California, Colorado, Illinois, Missouri, Nevada
2025-02-01
Recruiting
BOOM-IBD2 Pivotal Clinical Trial
NCT06571669Ulcerative Colitis, Inflammatory Bowel Diseases
Boomerang Medical
Not applicable
137
California, Kansas, Minnesota, Mississippi, Missouri, Nevada, New York, North Carolina
2025-01-31
Active, closed
AlloSource
Observational
100
Nevada
2025-01-27
Recruiting
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
NCT06824064Metastatic Colorectal Cancer, Advanced Colorectal Cancer
Riboscience, LLC.
Phase 2
150
Delaware, Nevada, Tennessee, Texas
2025-01-17
Recruiting
Laminate Medical Technologies
Not applicable
300
California, Florida, Georgia, Louisiana, Massachusetts, Mississippi, Nevada, South Carolina
2025-01-13
Active, closed
Beekeeper's Naturals Inc
Not applicable
100
Nevada
2024-12-30
Recruiting
Sanofi
Phase 2
84
Alabama, California, Florida, Georgia, Illinois, Michigan, Minnesota, Nevada
2024-12-19
Recruiting
ViiV Healthcare
Phase 1
168
Nevada, Texas
2024-12-16
Active, closed
Merck Sharp & Dohme LLC
Phase 2
120
Arizona, California, Georgia, Louisiana, Nevada, New Jersey, Texas, Wisconsin
2024-11-27
Recruiting
Shanghai Henlius Biotech
Phase 3
550
California, Colorado, Florida, Illinois, Iowa, Missouri, Nebraska, Nevada
2024-11-22
Active, closed
Sanofi
Phase 1/2
66
Arizona, California, Florida, Georgia, Illinois, Maryland, Massachusetts, Nevada
2024-11-21
Recruiting
Takeda
Phase 3
24
Alabama, Florida, Illinois, Indiana, Iowa, Michigan, Minnesota, Nevada
2024-11-06
Recruiting
AbbVie
Phase 3
264
California, Colorado, Florida, Illinois, Maryland, Missouri, Nevada, New Jersey
2024-11-05
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
California, Colorado, District of Columbia, Florida, Georgia, Illinois, Nevada, New York
2024-11-03
Active, closed
MBX Biosciences
Phase 2
60
Florida, Georgia, Mississippi, Missouri, Nevada, New York, Ohio, Texas
2024-10-31
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
320
California, Florida, Massachusetts, Nevada, New Jersey, North Carolina, Texas
2024-10-22
Active, closed
Merck Sharp & Dohme LLC
Phase 2
66
Iowa, Nevada, New York
2024-10-14
Recruiting
DiaSorin Molecular LLC
Not applicable
1,000
Nevada, Pennsylvania, Texas
2024-09-30
Recruiting
GAP Innovations, PBC
Observational
1,200
Florida, Illinois, Michigan, Nevada, New York, Ohio, Pennsylvania, Rhode Island
2024-09-26
Active, closed
Amgen
Phase 1
49
California, Colorado, Connecticut, Minnesota, Missouri, Nevada, New York, Oklahoma
2024-09-17
Active, closed
A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)
NCT06817343Neovascular Age-Related Macular Degeneration (nAMD), Neovascular (Wet) Age-related Macular Degeneration (AMD)
Exegenesis Bio
Phase 1
12
Nevada, Pennsylvania
2024-09-10
Active, closed
Cleo Diagnostics Ltd
Observational
1,000
Arizona, Florida, Illinois, Massachusetts, Nevada, New York, North Carolina, Ohio
2024-09-06
Active, closed
Skye Bioscience, Inc.
Phase 2
136
Alabama, California, Connecticut, Georgia, Kentucky, Nebraska, Nevada, New Hampshire
2024-08-22
Active, closed
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
NCT06577987Advanced Solid Tumor, Metastatic Solid Tumor, Refractory Solid Tumor, Cancer
Circle Pharma
Phase 1
220
Florida, Massachusetts, Michigan, Nevada, Ohio, Oregon, Tennessee, Texas
2024-08-14
By invitation
Viatris Innovation GmbH
Phase 3
680
Colorado, Florida, Louisiana, Nevada, Texas
2024-07-30
Active, closed
AbbVie
Phase 2
108
California, Kentucky, Maryland, Missouri, Nevada, New Jersey, New York, North Carolina
2024-07-29
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
California, Colorado, Florida, Georgia, Louisiana, Missouri, Nevada, North Carolina
2024-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Arizona, California, Colorado, Connecticut, Indiana, Michigan, Nevada, North Carolina
2024-07-16
Active, closed
Amgen
Phase 3
89
Arizona, Illinois, Michigan, Nevada, New Jersey, Oregon, Pennsylvania, Tennessee
2024-07-05
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
252
Colorado, Connecticut, Florida, Kentucky, Missouri, Nevada, New Mexico, Oklahoma
2024-06-04
Active, closed
Amgen
Phase 1/2
94
Arkansas, California, Florida, Illinois, Massachusetts, Nevada, Pennsylvania, Texas
2024-05-30
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
500
Colorado, Connecticut, Florida, Nevada, Ohio, Texas
2024-05-01
Active, closed
EpicentRx, Inc.
Phase 2
216
Arizona, Florida, Illinois, Indiana, Louisiana, Maryland, Michigan, Nevada
2024-04-02
By invitation
Clinical Registry Collecting Real World Evidence on Wound Care Treatments
NCT06328010Wounds and Injuries, Burns, Mohs Surgery, Diabetic Foot Ulcer Mixed
Siddhey LLC
Observational
5,000
Arizona, California, Florida, Illinois, Nevada, Texas
2024-04-01
Active, closed
Urotronic Inc.
Observational
500
Florida, Nebraska, Nevada, New York, Oregon, Texas, Virginia
2024-03-30
Active, closed
Takeda
Phase 2
213
California, Florida, Georgia, Kentucky, Maryland, Nevada, Rhode Island, South Carolina
2024-03-29
Recruiting
ViiV Healthcare
Phase 1
348
Kansas, Nevada, Texas, Utah
2024-03-21
Active, closed
ProVIDE II Bridging Study
NCT06236802BPH With Symptomatic Lower Urinary Tract Symptoms
ProVerum Medical
Not applicable
40
Florida, Illinois, Nevada, Texas
2024-03-06
Active, closed
DexCom, Inc.
Observational
5,000
Georgia, Nevada
2024-02-28
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
OnKure, Inc.
Phase 1
200
California, Colorado, Massachusetts, Nevada, New York, Tennessee, Virginia, Washington
2024-02-26
Active, closed
Parkinson's Disease Progression Study
NCT06219629Parkinson Disease
Koneksa Health
Observational
82
Colorado, Florida, Georgia, Kansas, Massachusetts, Michigan, Nevada
2024-02-20
Active, closed
Tourmaline Bio, Inc., a Novartis Company
Phase 2
79
Arizona, California, Colorado, Florida, Massachusetts, Michigan, Nevada, New Jersey
2024-02-19
Active, closed
Janssen Research & Development, LLC
Phase 2
305
Arizona, California, Georgia, Illinois, Missouri, Nevada, New Jersey, New York
2024-02-16
Active, closed
Boehringer Ingelheim
Phase 3
428
Alabama, Arizona, California, Missouri, Nevada, New York, North Carolina, Ohio
2024-02-09
Recruiting
Urotronic Inc.
Not applicable
92
Arkansas, Florida, Louisiana, Nevada, Oregon, Texas
2024-02-07
Active, closed
Kyowa Kirin Co., Ltd.
Phase 2
185
Arizona, California, Colorado, Florida, Maryland, Nevada, New Jersey, New Mexico
2024-01-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Arizona, California, Colorado, Massachusetts, Michigan, Nevada, New York, North Carolina
2023-12-31
Recruiting
Aadi Bioscience, Inc.
Phase 2
29
Arkansas, Florida, Nevada, New York, North Carolina, Oklahoma, Rhode Island, Texas
2023-12-28
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc.
Phase 3
285
Nevada, Ohio, Texas
2023-12-18
Active, closed
AnaptysBio, Inc.
Phase 2
132
Arizona, California, Florida, Georgia, Illinois, Nevada, New York, Ohio
2023-12-04
Active, closed
Nektar Therapeutics
Phase 2
396
Arkansas, California, Florida, Georgia, Indiana, Kentucky, Michigan, Nevada
2023-11-15
Recruiting
MBrace Therapeutics
Phase 1/2
130
California, Colorado, Georgia, Illinois, Indiana, Michigan, Nevada, New Jersey
2023-11-07
Active, closed
Ipsen
Observational
1,057
California, Florida, Maryland, Massachusetts, Missouri, Nebraska, Nevada, North Carolina
2023-11-01
Recruiting
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
NCT05953090Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva
Stratpharma AG
Not applicable
2,000
Alabama, California, Florida, Georgia, Nevada, North Carolina, South Carolina, Tennessee
2023-10-30
Active, closed
Chengdu Origen Biotechnology Co., Ltd.
Phase 1
25
Arizona, Illinois, Massachusetts, Nevada, New Jersey, Tennessee, Texas
2023-10-16
Recruiting
Hoffmann-La Roche
Phase 3
230
Arizona, California, District of Columbia, Maryland, Massachusetts, Michigan, Nevada, New Jersey
2023-09-08
Recruiting
Luminopia
Observational
500
California, Florida, Georgia, Hawaii, Illinois, Indiana, Nevada, New Hampshire
2023-09-01
Active, closed
Bavarian Nordic
Phase 3
715
Alabama, Arizona, Florida, Illinois, Kansas, Kentucky, Missouri, Nevada
2023-08-30
Active, closed
Erasca, Inc.
Phase 1
86
California, Connecticut, Florida, Georgia, Michigan, Missouri, Nevada, Oregon
2023-08-17
Recruiting
DualityBio Inc.
Phase 1/2
862
Arizona, California, Florida, Georgia, Kentucky, Michigan, Minnesota, Nevada
2023-08-17
Active, closed
Hoffmann-La Roche
Phase 3
459
Alabama, California, Florida, Georgia, Idaho, Illinois, Massachusetts, Nevada
2023-08-08
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc.
Phase 2
220
Alabama, California, Massachusetts, Nevada, New Jersey, New York, Ohio, Tennessee
2023-07-31
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
California, Georgia, Illinois, Indiana, Maryland, Minnesota, Missouri, Nevada
2023-07-17
Recruiting
Exai Bio Inc.
Observational
2,400
California, Nevada
2023-07-14
Active, closed
Viatris Innovation GmbH
Phase 3
451
Arizona, California, Florida, Louisiana, Nevada, New York, Texas
2023-06-26
Active, closed
Alumis Inc
Phase 2
408
Alabama, California, Florida, Georgia, Missouri, Nevada, New Jersey, New Mexico
2023-06-26
Active, closed
Abbisko Therapeutics Co, Ltd
Phase 1
169
California, Michigan, Nevada, Ohio
2023-06-26
Active, closed
Post-Market Registry in Europe and US for the Use of VascuCelTM
NCT04906824Great Vessel Reconstruction, Peripheral Vessel Reconstruction, Suture Line Buttressing
LeMaitre Vascular
Observational
100
Idaho, Nevada, New York, North Carolina
2023-06-09
Active, closed
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
NCT05778071Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases
Alexion Pharmaceuticals, Inc.
Phase 3
165
California, Colorado, Illinois, Indiana, Massachusetts, Minnesota, Nevada, New York
2023-06-07
Active, closed
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
NCT05870488Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Disorder, Sacroiliac Joint Pain
SI-BONE, Inc.
Phase 4
110
California, Indiana, Kansas, Kentucky, Maryland, Missouri, Nevada, Oklahoma
2023-05-23
Recruiting
Vaneltix Pharma, Inc.
Phase 2
120
California, Florida, Georgia, Louisiana, Massachusetts, Nevada, New York, North Carolina
2023-05-22
Active, closed
Stemline Therapeutics, Inc.
Phase 2
61
Arkansas, Illinois, Nevada, Texas
2023-05-19
Active, closed
Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries
NCT05744414Breast Implant; Complications, Infection or Inflammation
AlloSource
Observational
30
Nevada
2023-05-17
Active, closed
BeOne Medicines
Phase 2/3
178
California, Minnesota, Nevada
2023-04-17
Active, closed
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
NCT05662397Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer
HotSpot Therapeutics, Inc
Phase 1/2
77
Florida, Nevada, New York, Oregon, Pennsylvania, Texas
2023-03-15
Active, closed
AstraZeneca
Phase 2
188
California, Nevada, New York
2023-03-06
Recruiting
BeiGene
Observational
111
Alabama, California, Mississippi, Nevada
2023-03-03
Recruiting
Totus Medicines
Phase 1
241
California, Florida, Illinois, Maryland, Massachusetts, Nevada, Oregon, Pennsylvania
2023-02-15
Recruiting
Housey Healthcare ULC
Phase 2
300
California, Florida, Georgia, Kansas, Louisiana, Michigan, Nebraska, Nevada
2023-02-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
California, Florida, Illinois, Indiana, Kansas, Kentucky, Missouri, Nevada
2023-01-11
Active, closed
Sanofi
Phase 2
187
California, Georgia, Illinois, Missouri, Nevada, New Jersey, New York, Tennessee
2022-11-25
Recruiting
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NCT04757116Benign Prostatic Hyperplasia (BPH)
Olympus Corporation of the Americas
Not applicable
256
Arizona, California, Illinois, Louisiana, Minnesota, Nebraska, Nevada, New York
2022-09-26
Active, closed
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
NCT05464784Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
MediciNova
Phase 2
40
Nevada, Texas
2022-08-22
Active, closed
Iantrek, Inc.
Observational
300
California, Florida, Georgia, Maryland, Nevada, New Jersey, New York, Pennsylvania
2022-08-17
Active, closed
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
NCT05607810Diabetic Macular Edema, Diabetic Retinopathy
Adverum Biotechnologies, Inc.
Observational
22
California, Nevada, Pennsylvania, Texas
2022-08-10
Active, closed
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
NCT05032040Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer, Cervical Carcinoma
Xencor, Inc.
Phase 2
170
Arizona, California, Colorado, Delaware, Florida, Georgia, Michigan, Nevada
2022-07-21
Active, closed
DualityBio Inc.
Phase 1/2
1,123
Arizona, California, District of Columbia, Florida, Hawaii, Illinois, Michigan, Nevada
2022-07-19
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Alabama, California, Florida, Georgia, Louisiana, Michigan, Nevada, New York
2022-07-14
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Alabama, Arizona, California, Florida, Kentucky, Nevada, South Dakota, Texas
2022-06-30
Active, closed
ProVee Urethral Expander System IDE Study (ProVIDE)
NCT05186740BPH With Symptomatic Lower Urinary Tract Symptoms
ProVerum Medical
Not applicable
221
California, Florida, Illinois, Nevada, New York, North Carolina, Texas, Virginia
2022-06-09
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
49
Arizona, California, Georgia, Massachusetts, Nevada, New York, Pennsylvania, Texas
2022-06-08
Active, closed
Fujifilm Pharmaceuticals U.S.A., Inc.
Phase 2
120
California, District of Columbia, Kansas, Kentucky, Michigan, Missouri, Nebraska, Nevada
2022-06-01
Active, closed
Shanghai Henlius Biotech
Phase 3
511
California, Colorado, Connecticut, Florida, Kansas, Louisiana, Minnesota, Nevada
2022-05-17
Active, closed
AbbVie
Phase 2
103
Arizona, California, Georgia, Illinois, Maryland, Massachusetts, Nevada, New Jersey
2022-04-04
Active, closed
Hoffmann-La Roche
Phase 2
109
California, Nevada
2022-03-01
Active, closed
Urotronic Inc.
Phase 4
34
Arkansas, Florida, Louisiana, Maryland, Nevada, New Jersey, New York, Texas
2022-02-14
Active, closed
Insignia™ Hip Stem Outcomes Study
NCT05144191Hip Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Osteoarthritis
Stryker Orthopaedics
Not applicable
313
Arizona, California, Illinois, Nevada, New York, North Carolina, Pennsylvania, Tennessee
2022-02-07
Active, closed
Curevo Inc
Phase 2
1,516
Arizona, Florida, Illinois, Kansas, Kentucky, Nevada, Oklahoma, Tennessee
2022-02-02
Active, closed
Noema Pharma AG
Phase 2/3
166
California, Florida, Georgia, Massachusetts, Nevada, New York, Ohio
2022-01-11
By invitation
AbbVie
Phase 2
116
Arizona, California, Georgia, Maryland, Massachusetts, Minnesota, Nevada, New Mexico
2021-12-20
Active, closed
Desara ® One Single Incision Sling 522 Study
NCT04772131Stress Urinary Incontinence
Caldera Medical, Inc.
Not applicable
300
Arizona, Florida, Idaho, Indiana, Kentucky, Massachusetts, Missouri, Nevada
2021-11-01
Active, closed
AstraZeneca
Phase 3
927
Arkansas, California, Connecticut, Indiana, Kentucky, Louisiana, Minnesota, Nevada
2021-10-25
Active, closed
Paradigm Biopharmaceuticals USA (INC)
Phase 2/3
602
Arizona, California, Florida, Illinois, Kansas, Louisiana, Nevada, South Carolina
2021-10-19
Recruiting
Helix Research Network
NCT06057181Genetic Predisposition to Disease, Genetics Disease
Helix, Inc
Observational
10,000,000
Indiana, Minnesota, Nebraska, Nevada, New York, North Carolina, Ohio, Pennsylvania
2021-09-13
Recruiting
Freedom-1 Study for Chronic Knee Pain
NCT03877653Osteoarthritic Knee Pain
Curonix LLC
Not applicable
100
California, Colorado, Florida, Georgia, Nevada, Ohio, Texas
2021-09-01
Active, closed
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
NCT04403022Colorectal Cancer, Benign or Malignant Rectal or Colon Tumors
Intuitive Surgical
Not applicable
60
Florida, Michigan, Minnesota, Nevada, Pennsylvania, Texas, Washington
2021-06-03
Active, closed
Abbott Diabetes Care
Observational
550
Connecticut, Missouri, Nevada
2021-06-01
Active, closed
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease
Novartis Pharmaceuticals
Phase 2
103
California, Colorado, Louisiana, Massachusetts, Minnesota, Nevada, North Carolina, Texas
2021-03-15
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
California, Florida, Georgia, Illinois, Iowa, Michigan, Nevada, New York
2021-02-23
Active, closed
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
NCT04645212Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
Observational
23
California, Colorado, Florida, Nevada, Pennsylvania, Tennessee, Texas
2020-12-14
Active, closed
Intra-IMMUSG Pte Ltd
Phase 2
51
Arizona, California, Kentucky, Nevada
2020-12-12
Active, closed
GlaxoSmithKline
Phase 2/3
758
California, Connecticut, District of Columbia, Hawaii, Iowa, Kentucky, Nevada, New York
2020-12-08
Active, closed
AstraZeneca
Phase 3
370
Arizona, Illinois, Kansas, Massachusetts, Michigan, Minnesota, Missouri, Nevada
2020-10-02
Active, closed
ADC Therapeutics S.A.
Phase 3
440
California, Florida, Iowa, Kentucky, Nevada, Oregon, South Carolina, Virginia
2020-09-16
Active, closed
AbbVie
Phase 2
146
Arizona, California, Georgia, Illinois, Maryland, Massachusetts, Nevada, New Mexico
2020-08-25
Active, closed
Eisai Inc.
Phase 1
31
Florida, Massachusetts, Missouri, Nevada, Tennessee
2020-04-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
California, Florida, Georgia, Idaho, Kansas, Kentucky, Missouri, Nevada
2020-02-27
Recruiting
MDR - PMCF Study for Taperloc Complete Stems
NCT04028687Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries
Zimmer Biomet
Observational
820
Nevada, Texas, Washington
2020-02-13
Active, closed
Optilume™ BPH Catheter System in Men With Symptomatic BPH
NCT04131907Benign Prostatic Hyperplasia
Urotronic Inc.
Not applicable
162
Arkansas, Colorado, Florida, Illinois, Louisiana, Maryland, Nevada, New Jersey
2020-02-05
Active, closed
Bausch Health Americas, Inc.
Phase 4
2
California, Florida, Nevada
2020-01-24
Active, closed
RhoVac APS
Phase 2
180
Florida, Maryland, Nebraska, Nevada, New York, South Carolina, Texas
2019-11-19
Active, closed
TG Therapeutics, Inc.
Phase 3
1,100
California, Colorado, Florida, Illinois, Kansas, Michigan, Nevada, New Jersey
2019-11-18
Active, closed
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
BicycleTx Limited
Phase 1/2
288
California, Colorado, Florida, Michigan, Nevada, New York, Oklahoma, Pennsylvania
2019-11-07
By invitation
Rigel Pharmaceuticals
Phase 3
90
California, District of Columbia, Maryland, Massachusetts, Nevada, Washington
2019-10-30
Active, closed
MedImmune LLC
Phase 1/2
61
California, Michigan, Nevada, New York, Ohio, Rhode Island, Tennessee, Texas
2019-09-13
Active, closed
BeOne Medicines
Phase 3
510
California, Illinois, Massachusetts, Michigan, Nevada, New York, Oregon, Pennsylvania
2019-08-20
Active, closed
AstraZeneca
Phase 3
587
California, Florida, Kansas, Kentucky, Massachusetts, Nevada, New York, Ohio
2019-07-02
By invitation
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
NCT03999801Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
AbbVie
Phase 2
865
Arizona, California, Maryland, Massachusetts, Nevada, Pennsylvania, Tennessee, Texas
2019-05-31
Recruiting
Abbott Medical Devices
Observational
2,000
Arizona, California, Florida, Illinois, Indiana, Minnesota, Missouri, Nevada
2019-03-13
Recruiting
RedDress Ltd.
Observational
500
Nevada
2019-02-14
Recruiting
Exactech
Observational
1,000
Colorado, Florida, Nevada, Ohio, South Carolina
2019-01-23
Active, closed
Early Weight-Bearing After the Lapiplasty Procedure
NCT03740282Hallux Valgus, Bunion
Treace Medical Concepts, Inc.
Not applicable
183
Colorado, Iowa, Missouri, Nevada, Pennsylvania, Texas
2018-11-06
Active, closed
Smith & Nephew, Inc.
Observational
126
Minnesota, Nevada, South Carolina, Tennessee
2018-08-26
Recruiting
Hoffmann-La Roche
Phase 1/2
1,132
California, Colorado, Florida, Illinois, Minnesota, Nebraska, Nevada, New Jersey
2018-03-30
Recruiting
Octapharma
Observational
200
Florida, Louisiana, Missouri, Nevada, Texas
2018-02-13
Active, closed
BeiGene
Phase 3
590
Georgia, Illinois, Massachusetts, Missouri, Nevada, New Jersey, New York, North Carolina
2017-10-31
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
California, Colorado, Florida, Kentucky, Nevada, New Hampshire, New York, Oregon
2017-09-22
Active, closed
JOURNEY II XR Safety and Effectiveness PMCF
NCT03136887Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee, Unilateral Post-Traumatic Osteoarthritis of Knee, Knee Osteoarthritis, Degenerative Arthritis Peripheral Joint
Smith & Nephew, Inc.
Observational
176
California, Florida, Illinois, Maryland, Michigan, Nevada, New Jersey, New York
2017-07-28
Active, closed
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell, Graft Vs Host Disease
Pharmacyclics Switzerland GmbH
Phase 4
297
California, Georgia, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Jersey
2017-05-22
Active, closed
Candel Therapeutics, Inc.
Phase 2
187
Colorado, Illinois, Louisiana, Maryland, Missouri, Nevada, New Jersey, New York
2016-05
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Arizona, California, Connecticut, Florida, Illinois, Louisiana, Nevada, New York
2015-12
Active, closed
Eli Lilly and Company
Phase 3
493
Arizona, Arkansas, California, Florida, Georgia, Minnesota, Nebraska, Nevada
2014-11-06
Active, closed
A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
NCT01542580Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis, Post Traumatic Deformity
Zimmer Biomet
Observational
255
Illinois, Nevada, Utah, Virginia
2012-03
Active, closed
Optetrak Knee System Post Market Clinical Follow-Up
NCT05788757Knee Arthroplasty, Total
Exactech
Observational
4,588
Massachusetts, Nevada, South Carolina
2011-06-01
Rows per page Showing 1–312 of 312
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-usa/state/nevada

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,148 studies in total at the last sync on 21 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 312 of those studies with a site in Nevada.

How many clinical trials are recruiting in Nevada?

152 of the 312 studies on this page are recruiting new participants as of the 21 Nov 2026, 03:16 UTC sync. A further 10 have not yet opened recruitment, 142 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nevada), 312 studies
PhaseStudiesRecruitingShare
Phase 3784125%
Phase 2753424%
Not applicable532017%
Observational361811.5%
Phase 129169.3%
Phase 1/219116.1%
Phase 41273.8%
Phase 2/31053.2%

Most active sponsors

Lead sponsors with the most studies (Nevada)
Lead sponsorStudiesRecruiting
AbbVie104
AstraZeneca104
Merck Sharp & Dohme LLC92
Eli Lilly and Company85
Hoffmann-La Roche83
Sanofi64
Amgen50
Novartis Pharmaceuticals52
GlaxoSmithKline42
Novo Nordisk A/S42
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.